LIA
ABBV icon

Luken Investment Analytics’s AbbVie ABBV Stock Holding History

Luken Investment Analytics’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Hold
131
– – 0.01% 115
2026
Q1 		$28.5K Sell
131
-12
-8% -$2.66K 0.01% 114
2025
Q4 		$32.7K Buy
143
+59
+70% +$13.4K 0.01% 108
2025
Q3 		$19.4K Hold
84
– – 0.01% 117
2025
Q2 		$15.6K Hold
84
– – 0.01% 119
2025
Q1 		$17.6K Hold
84
– – 0.01% 117
2024
Q4 		$14.9K Hold
84
– – 0.01% 113
2024
Q3 		$16.6K Hold
84
– – 0.01% 105
2024
Q2 		$14.4K Hold
84
– – 0.01% 120
2024
Q1 		$15.3K Hold
84
– – 0.01% 106
2023
Q4 		$13K Hold
84
– – 0.01% 111
2023
Q3 		$12.5K Hold
84
– – 0.01% 113
2023
Q2 		$11.3K Hold
84
– – 0.01% 114
2023
Q1 		$13.4K Hold
84
– – 0.01% 107
2022
Q4 		$13.6K Buy
+84
New +$12.9K 0.01% 105
2020
Q4 		$9K Buy
+84
New +$8.07K 0.01% 86

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Luken Investment Analytics's ABBV Position: Q2 2026 in Review

Luken Investment Analytics held its AbbVie (ABBV) position steady in Q2 2026 at 131 shares worth $33K. The position accounts for 0.01% of the portfolio, ranked #115.

Luken Investment Analytics first reported a position in ABBV in Q4 2020 and has held it in 16 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Luken Investment Analytics held 131 shares of AbbVie worth $33K as of Q2 2026.
  • Luken Investment Analytics left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.01% of Luken Investment Analytics's portfolio in Q2 2026, its #115 holding.
  • Luken Investment Analytics first reported a position in AbbVie in Q4 2020 and has held it in 16 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Luken Investment Analytics's 13F filing for Q2 2026, filed 28 Jul 2026.